Search Results
Found 3 results
510(k) Data Aggregation
(44 days)
MODIFICATION TO SUPERDIMENSION/BRONCHUS PREMIUM 2
Indicated for displaying images of the tracheobronchial tree to aid the physician in guiding endoscopic tools in the pulmonary tract. It does not make a diagnosis and is not an endoscopic tool. Not for pediatric use.
The superDimension/Bronchus Premium 2 is a device that guides a bronchoscope and bronchial tool to a target in or adjacent to the bronchial tree on a path indicated by CT scan, and visualizes the target and the interior of the tree.
The provided text is a 510(k) summary for the superDimension/Bronchus Premium 2 device, dated July 12, 2007. It describes changes made to an already cleared device (K062315).
Based on the document, the following observations can be made regarding acceptance criteria and the study:
1. A table of acceptance criteria and the reported device performance:
The document states: "Appropriate verification and validation tests were performed to assure that the design output met the design input requirements and that the modified device continues to meet its user needs and intended uses." However, specific quantitative acceptance criteria and reported device performance are not detailed in this 510(k) summary. This summary focuses on the administrative aspects of a special 510(k) and asserts that the device continues to meet its previous requirements rather than establishing new ones or reporting specific performance metrics for the modified device.
2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective):
The document explicitly states: "Clinical tests were not required to validate the changes made to the superDimension/Bronchus Premium 2." This indicates that no new clinical test data was generated, and therefore, there is no sample size for a test set or data provenance to report from this specific submission. The submission relies on the substantial equivalence to the predicate device and the verification and validation (V&V) activities against design inputs for the modified components.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience):
As no clinical tests were required, no experts were used to establish ground truth for a test set related to this submission.
4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:
Since no clinical tests were required, there was no adjudication method employed for a test set in this submission.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
The device described is a navigation system for bronchoscopy, not an AI or imaging interpretation device. Therefore, a multi-reader multi-case (MRMC) comparative effectiveness study was not conducted for this device, and there is no mention of AI assistance or its effect size.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
This device is not an algorithm that performs standalone analysis. It is a system that aids a physician in guiding endoscopic tools. Therefore, no standalone algorithm-only performance study was conducted.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):
As no clinical testing was performed for this specific 510(k) submission, no new ground truth data was generated or used. The assessment relies on the existing clearance of the predicate device and the V&V activities.
8. The sample size for the training set:
The document does not describe any machine learning or AI components that would require a training set. Therefore, no sample size for a training set is provided.
9. How the ground truth for the training set was established:
As there is no mention of a training set, the question of how its ground truth was established is not applicable to this document.
Ask a specific question about this device
(30 days)
SUPERDIMENSION/BRONCHUS PREMIUM 2
Indicated for displaying images of the tracheobronchial tree to aid the physician in guiding endoscopic tools in the pulmonary tract. It does not make a diagnosis and is not an endoscopic tool.
The superDimension/Bronchus Premium is a device that guides a bronchoscope and bronchial tool to a target in or adjacent to the bronchial tree on a path indicated by CT scan, and visualizes target and the interior of the tree. It has been modified to permit connection to PACS and import of PET/CT image data. Other minor improvements have been made also.
The provided text states, "Since no new technology is used, clinical tests are not required." Therefore, the device did not undergo clinical testing to establish acceptance criteria or demonstrate performance.
Here's a breakdown of the requested information based on the provided document, even though a clinical study fulfilling these criteria was not conducted:
1. Table of Acceptance Criteria and Reported Device Performance
Not applicable. No acceptance criteria or performance metrics derived from clinical trials are mentioned.
2. Sample Size for Test Set and Data Provenance
Not applicable. No clinical test set.
3. Number of Experts Used to Establish Ground Truth and Their Qualifications
Not applicable. No ground truth established from expert review in a clinical study.
4. Adjudication Method
Not applicable. No clinical test with adjudication.
5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study
Not applicable. No MRMC study was performed or reported.
6. Standalone (Algorithm Only) Performance Study
Not applicable. The device is a guidance system, and the document explicitly states "It does not make a diagnosis and is not a bronchial tool." It's not an AI algorithm performing a diagnostic task in a standalone manner.
7. Type of Ground Truth Used
Not applicable. No clinical ground truth was established through expert consensus, pathology, or outcomes data as clinical tests were not required.
8. Sample Size for the Training Set
Not applicable. This device is a guidance system, not an AI algorithm trained on a dataset.
9. How the Ground Truth for the Training Set Was Established
Not applicable. No training set for an AI algorithm.
Summary of Device Information provided in the text:
- Device Name: superDimension/Bronchus Premium 2
- Intended Use: To image the upper airways and tracheobronchial tree to aid the physician in guiding endoscopic tools in the pulmonary tract. It does not make a diagnosis and is not a bronchial tool.
- Modifications from Predicate: Modified to permit connection to PACS and import of PET/CT image data. Other minor improvements.
- Performance Data: Non-clinical tests included satisfying EN60601-1 and EN 60601-1-2 requirements and extensive bench testing.
- Reason for no Clinical Tests: "Since no new technology is used, clinical tests are not required." This indicates that the FDA deemed the changes to the device minor enough that new clinical data was not necessary to demonstrate substantial equivalence to the predicate device (superDimension/Bronchus Premium, K052852).
Ask a specific question about this device
(34 days)
SUPERDIMENSION/BRONCHUS PREMIUM
Indicated for displaying images of the tracheobronchial tree to aid the physician in guiding endoscopic tools in the pulmonary tract. It does not make a diagnosis and is not an endoscopic tool.
The superDimension/Bronchus Premium is a device that guides a bronchoscope and bronchial tool to a target in or adjacent to the bronchial tree on a path indicated by CT scan, and visualizes nearnet aod the interior of the tree. It has been modified to permit external video monitoring and recording devices. Other minor improvements have been made also.
The provided text describes the superDimension/Bronchus Premium device but does not contain information about acceptance criteria or a study proving the device meets specific performance criteria.
The document is a 510(k) summary for a Special 510(k), which implies that the device is substantially equivalent to a previously cleared device (superDimension/Bronchus 4.1, K052260) and incorporates minor modifications.
Here's a breakdown of why the requested information is absent based on the provided text:
- Acceptance Criteria and Reported Device Performance: This information is not present. The document states, "Since no new technology is used, clinical tests are not required." This indicates that the device's performance was not evaluated through a new clinical study with pre-defined acceptance criteria, but rather by demonstrating substantial equivalence to a predicate device.
- Sample size for the test set and data provenance: No test set is mentioned because no new clinical testing was deemed necessary.
- Number of experts and their qualifications: Not applicable as no new ground truth establishment process is described.
- Adjudication method: Not applicable.
- Multi-Reader Multi-Case (MRMC) comparative effectiveness study: Not conducted or mentioned.
- Standalone (algorithm only) performance: Not applicable, as this is a device for guiding a bronchoscope, not a diagnostic algorithm.
- Type of ground truth used: Not applicable as no new clinical study to establish ground truth was performed.
- Sample size for the training set: Not applicable as "no new technology is used."
- How the ground truth for the training set was established: Not applicable.
Summary from the provided text:
Information Requested | суперDimension/Bronchus Premium |
---|---|
1. Acceptance Criteria and Reported Device Performance | Not provided a new study. The device satisfied EN60601-1 and EN 60601-1-2 and underwent extensive bench testing. Its substantial equivalence to superDimension/Bronchus 4.1 (K052260) was used for clearance. |
2. Sample size for test set & data provenance | Not applicable; no new clinical tests were required. |
3. Number and qualifications of experts for ground truth | Not applicable; no new clinical tests were required. |
4. Adjudication method | Not applicable; no new clinical tests were required. |
5. MRMC comparative effectiveness study | No. |
6. Standalone performance study | No. |
7. Type of ground truth used | Not applicable; no new clinical tests were required. |
8. Sample size for training set | Not applicable; no new technology was used, and no new clinical tests were required. |
9. How ground truth for training set was established | Not applicable; no new technology was used, and no new clinical tests were required. |
Reasoning for "Not applicable":
The document explicitly states: "Since no new technology is used, clinical tests are not required." This means that the device's clearance was based on its substantial equivalence to a predicate device, rather than new clinical data demonstrating its performance against specific acceptance criteria. The modifications were minor, primarily allowing external video monitoring/recording and other minor improvements. Therefore, the detailed information about clinical studies, test sets, ground truth establishment, and expert involvement is not present in this 510(k) summary.
Ask a specific question about this device
Page 1 of 1